These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2616600)

  • 1. Effects of exercise on behavioral sensitivity to carbamate cholinesterase inhibitors.
    McMaster SB; Finger AV
    Pharmacol Biochem Behav; 1989 Aug; 33(4):811-3. PubMed ID: 2616600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of pyridostigmine bromide on progressive ratio performance in male and female rats.
    van Haaren F; Haworth SC; Bennett SM; Cody BA
    Pharmacol Biochem Behav; 2001 Jan; 68(1):81-5. PubMed ID: 11274711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic exercise produces tolerance to muscarinic antagonists in rats.
    McMaster SB; Carney JM
    Pharmacol Biochem Behav; 1986 Apr; 24(4):865-8. PubMed ID: 3714778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats.
    Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M
    Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of oral pyridostigmine bromide on conditioned operant performance in rats.
    Shih JH; Liu WF; Lee SF; Lee JD; Ma C; Lin CH
    Pharmacol Biochem Behav; 1991 Mar; 38(3):549-53. PubMed ID: 2068191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to oxotremorine's effects on schedule-controlled behavior in physostigmine-tolerant rats.
    Genovese RF; Elsmore TF; King LR
    Life Sci; 1988; 43(7):571-6. PubMed ID: 3398709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carbamates upon various behavioural parameters in mice.
    Arndt H; Sprengard M
    Arch Toxicol Suppl; 1989; 13():378-80. PubMed ID: 2774964
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of pyridostigmine bromide, permethrin, and DEET alone, or in combination, on fixed-ratio and fixed-interval behavior in male and female rats.
    van Haaren F; Haworth SC; Bennett SM; Cody BA; Hoy JB; Karlix JL; Tebbett IR
    Pharmacol Biochem Behav; 2001; 69(1-2):23-33. PubMed ID: 11420065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pyridostigmine and physostigmine on acute toxicity of diisopropyl fluorophosphate in rats.
    Husain K; Vijayaraghavan R; Marjit DN
    Arh Hig Rada Toksikol; 1990 Mar; 41(1):19-24. PubMed ID: 2396896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced changes in schedule controlled behavior.
    McMaster SB; Carney JM
    Physiol Behav; 1985 Sep; 35(3):337-41. PubMed ID: 4070405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
    Blick DW; Miller SA; Brown GC; Murphy MR
    Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to behavioral effects of physostigmine under interval schedules of positive or negative reinforcement.
    Galbicka G; Elsmore TF; Witkin JM
    Psychopharmacology (Berl); 1989; 97(4):448-55. PubMed ID: 2498941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
    Buccafusco JJ; Li W
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman.
    Harris LW; Lennox WJ; Talbot BG; Anderson DR; Swanson DR
    Drug Chem Toxicol; 1984; 7(5):507-26. PubMed ID: 6510256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental influences on the development of tolerance to the effects of physostigmine on schedule-controlled behavior.
    Genovese RF; Elsmore TF; Witkin JM
    Psychopharmacology (Berl); 1988; 96(4):462-7. PubMed ID: 3149767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of effects of anatoxin-a(s) and paraoxon, physostigmine and pyridostigmine on mouse brain cholinesterase activity.
    Cook WO; Beasley VR; Dahlem AM; Dellinger JA; Harlin KS; Carmichael WW
    Toxicon; 1988; 26(8):750-3. PubMed ID: 3188065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration.
    Grauer E; Alkalai D; Kapon J; Cohen G; Raveh L
    Toxicol Appl Pharmacol; 2000 May; 164(3):301-4. PubMed ID: 10799340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.